This checks out

Chief fellow !! Proud of Jaclyn Tuck 🙈

Oropouche virus, which causes a dengue-like illness, is spreading across regions of Latin America & the Caribbean. Our study identifies the likely locations where travelers may present with this infection upon returning from these areas. tinyurl.com/2k35a8yp in Journal of Travel Medicine.

🙌

Research 🤯

Day 2 of #IDWeek2024 with unforgettable tropical medicine/global health cases! 🤯

One of the best parts of #IDWeek2024 is seeing my day 1 mentor !! Janis Blair Mayo Clinic Infectious Diseases

The actual best part of fellowship is the crew

Some fantastic NTM in immunocompromised hosts learning this morning. Challenging cases! #IDWeek2024

Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia - Challenges the dogma. #IDWeek2024 pubmed.ncbi.nlm.nih.gov/38831614/

Just some #TxID fellows at #IDWeek2024 MGB Infectious Diseases Fellowship MGH Division of Infectious Diseases

Excited to share our research on Cocci antifungal ppx in SOT! TLDR; For patients repeatedly pos for EIA-IgM-only w no seroconversion, compatible clinical illness, or rads findings, discontinuing antifungal ppx may be reasonable after 1st posttxp yr journals.lww.com/transplantjour…

Ontario is reporting 557 cases of measles so far in 2025. We had 64 cases for all of 2024.

Amazing review by Drs. Portales and Barshak!!

Excited to have the 4th international CMV consensus guidelines officially published!!

Checkout our viewpoint! TLDR; PCT guided strategies in sepsis should focus on antibiotic discontinuation, but its real benefit may be in early application in the ED to support diagnostic reasoning, triage, and stewardship.

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules doi.org/10.1093/cid/ci…

ID Update July Edition is out. Get it free inside the #SanfordGuideAntimicrobial app.

In Clinical Infectious Diseases, Jessica Little, MD and colleagues evaluate the immunologic, virologic, and clinical outcomes of dual/extended antiviral therapy in severely immunocompromised patients with protracted SARS-CoV-2 infection. academic.oup.com/cid/advance-ar…

Revising Sepsis Definitions to Better Target and Tailor Sepsis Care 🔗 bit.ly/4kQCyBO